Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis.

Shankar S. et al, (2022), Nat Commun, 13

Study Dataset for mHLA-DRd and Cancer Risk

Bottomley M. et al, (2021)

CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells.

Arroyo Hornero R. et al, (2020), Commun Biol, 3

Immune Tolerance and Rejection in Organ Transplantation.

Stolp J. et al, (2019), Methods Mol Biol, 1899, 159 - 180

Isolation of Human Regulatory T Lymphocytes by Fluorescence-Activated Cell Sorting.

Milward K. et al, (2019), Methods Mol Biol, 1899, 43 - 54

Regulatory T cells for tolerance.

Kawai K. et al, (2018), Hum Immunol, 79, 294 - 303

The Calcineurin Inhibitor Tacrolimus Specifically Suppresses Human T Follicular Helper Cells.

Wallin EF. et al, (2018), Front Immunol, 9

How to Escape the Immune Response: What Tumors Teach to Transplant Physicians/Immunologists.

Claisse G. et al, (2017), Transplantation, 101, 2825 - 2829

Selective blockade of CD28 on human T cells facilitates regulation of alloimmune responses.

Zaitsu M. et al, (2017), JCI Insight, 2

Enhancing human regulatory T cells in vitro for cell therapy applications.

Milward KF. et al, (2017), Immunol Lett, 190, 139 - 147

Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry.

Juvet SC. et al, (2017), J Vis Exp

CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression.

Arroyo Hornero R. et al, (2017), Transplantation, 101, 302 - 309

Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study.

Bottomley MJ. et al, (2017), Transplant Direct, 3

Editorial: Transplant Rejection and Tolerance-Advancing the Field through Integration of Computational and Experimental Investigation.

Raimondi G. et al, (2017), Front Immunol, 8

Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization.

Fuchs A. et al, (2017), Front Immunol, 8

TNFR2: The new Treg switch?

Cohen JL. and Wood KJ., (2017), Oncoimmunology, 7

Dominant iNKT cells subsets differentially control immunity to allografts according to the site of T cell priming

Jones ND. et al, (2016), EUROPEAN JOURNAL OF IMMUNOLOGY, 46, 757 - 757

B Cells and Antibodies in Transplantation.

Koenig A. et al, (2016), Transplantation, 100, 1460 - 1464

CD45RA identifies TSDR demethylated regulatory T cells with a stable phenotype and suppressive cytokine profile

Hornero RA. et al, (2016), TRANSPLANTATION, 100, S280 - S280

The UK ONE Study trial: safety and feasibility of regulatory T (Treg) cell therapy in renal transplantation

Bushell AR. et al, (2016), TRANSPLANTATION, 100, S120 - S120

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?